TFRC and cancer: We identified three potential biomarkers common to cancer, i.e. TFRC, VEGFA and MET as evidenced by: (i) gene over-expression in cancer compared to normal and inflammation; (ii) gene expression significantly linked to patient survival in at least two cancer types; (iii) corresponding CNV focally significantly amplified in tumors; (iv) proteins stain positive in more than 80% of cancers.